Subscribe Sign In

Why register?

Home
News
Events
- Find an event
- Live event coverage
Deep Dive
Sales and marketing
Digital
Market Access
Oncology
Patients
R&D
Spotlight On
- Frontiers Health 2022
- The Future of Generics
Advertise

Search

Search

Close

Trending

Health Innovators – Monique Levy

Deep Dive: Digital Health 2022

ViiV Healthcare study reveals outdated perceptions of HIV

Eisai’s full lecanemab phase 3 trial results for Alzheimer’s presented at CTAD

Expansion of CareQuest partnership with CIPCOH, funding ‘100 Million Mouths’

lyrica

AbbVie's Humira (adalimumab)

News/ News/ Sales and Marketing

Humira tops list of drugs with unwarranted US price hikes

Phil Taylor AbbVie, Amgen, Biogen, cialis, drug prices, Eli Lilly, Gilead Sciences, Humira, ICER, lyrica, Neulasta, Rituxan, Roche, Tecfidera, Truvada 0 Comment

AbbVie’s Humira heads a list of seven medicines that collectively contributed to a $5.1 billion increase in US

X

Humira tops list of drugs with unwarranted US price hikes

https://pharmaphorum.com/news/humira-tops-list-of-drugs-with-unwarranted-us-price-hikes/

Pfizer’s Lyrica fails phase 3 trial in epilepsy

News/ News/ R&D

Pfizer’s Lyrica fails phase 3 trial in epilepsy

George Underwood epilepsy, lyrica, Pfizer 0 Comment

Pfizer’s Lyrica has failed to meet its primary endpoint in a phase 3 trial in primary generalised tonic-clonic

X

Pfizer’s Lyrica fails phase 3 trial in epilepsy

https://pharmaphorum.com/news/pfizers-lyrica-fails-phase-3-trial-in-epilepsy/

Get in-depth news, opinions and features on pharma and healthcare sent straight to your inbox

Featured content

How to improve payer engagement with tailored value communication

How to improve payer engagement with tailored value communication

How will NICE fare in a post-Brexit world?

How will NICE fare in a post-Brexit world?

Events

Frontiers Health Steering Committee spotlight – Monique Levy

Frontiers Health Steering Committee spotlight – Monique Levy

MAPS 2018 EMEA Annual Meeting

MAPS 2018 EMEA Annual Meeting

Cell & Gene Therapy 2018

Cell & Gene Therapy 2018

Most popular

Most Viewed

AstraZeneca, MSD raise prostate cancer awareness with 'Never Miss' campaign
Eisai's full lecanemab phase 3 trial results for Alzheimer's presented at CTAD
Huge inequalities found in access to myeloma clinical trials in Europe, says MPE
SMC gives Bayer's CKD therapy Kerendia the green light in Scotland
ViiV Healthcare study reveals outdated perceptions of HIV

Tweets from @pharmaphorum

Tweets by @pharmaphorum

Advertise

Contribute
Work for pharmaphorum

About us
Contact us
Privacy policy
Terms & conditions
Cookie Policy

The rights of trade mark owners are acknowledged. pharmaphorum media limited

Website and content copyright © 2009-, pharmaphorum media limited or its licensors; all rights reserved.

© 2022

Powered by WordPress • Themify WordPress Themes

Login

Username or Email Address

Password

Remember Me

Lost your password?

CONTINUE TO SITE >

Close in 10 seconds

Pharmaphorum.com